Board of Directors

Ms. Miller has served as a director since February 2019 and became Stericycle’s President and Chief Executive Officer in May 2019 after serving as President and Chief Operating Officer since October 2018. Ms. Miller previously served as President, Global Freight Forwarding for United Parcel Service (‘‘UPS’’), a multinational package delivery and supply chain management company, from April 2016 to September 2018 and as President of UPS’s European region from March 2013 to March 2016. Ms. Miller served as a director of UGI Corporation from 2020 to 2024.

Brian P. Anderson has served as a director since January 2017. Mr. Anderson served as Senior Vice-President and Chief Financial Officer of OfficeMax Incorporated from 2004 to 2005 and as Senior Vice President and Chief Financial Officer of Baxter International from 1997 to 2004. He joined Baxter in 1991, as Vice President, Corporate Audit, and became Corporate Controller in 1993 and then Vice President, Finance in 1997. Before joining Baxter, he spent 15 years with Deloitte in the Chicago office and the Washington, D.C. office as an Audit Partner. He is a member of the Board of Directors of PulteGroup, Inc. He is the former Chairman of the Audit Committee of James Hardie, Plc., former Chairman of the Nemours Foundation, member of the Audit Committee of the PulteGroup, Inc., former member of the Board of Directors and Lead Director and Audit Committee Chairman of W.W. Grainger, Inc. and served on The Governing Board of the Center for Audit Quality, the Board of A.M. Castle & Co. from 2005 to 2016, as Audit Committee Chairman (2005-2010) and Chairman of the Board (2010-2016).

Lynn D. Bleil has served as a director since May 2015. Ms. Bleil, an experienced corporate director in the global healthcare industry, was the leader of the West Coast Healthcare Practice of McKinsey & Company (‘‘McKinsey’’), a management consulting firm. She retired in November 2013 as a Senior Partner (Director) in the Southern California Office of McKinsey. During her more than 25 years with McKinsey, she worked exclusively within the healthcare sector, advising senior management and boards of leading companies on corporate and business unit strategy, mergers and acquisitions and integration, marketing and sales, public policy and organization. Ms. Bleil also serves as a director of Amicus Therapeutics Inc., Alcon AG and Sonova Holdings AG, and as Chair of the Intermountain Wasatch Back Hospitals Community Board. She was formerly a director of DST Systems, Inc. and Auspex Pharmaceuticals, Inc.

Thomas F. Chen has served as a director since May 2014. Mr. Chen served as Senior Vice President and President of International Nutrition, Abbott Laboratories (‘‘Abbott’’) before retiring in 2010. During his 22-year career at Abbott, Mr. Chen served in a number of roles with expanding responsibilities, primarily in Pacific/Asia/Africa where he oversaw expansion into emerging markets. Prior to Abbott, he held several management positions at American Cyanamid Company, which later merged with Pfizer, Inc. Mr. Chen currently serves as an advisor to Cooperation Fund, a partnership between Goldman Sachs and the sovereign fund, China Investment Corporation, to bolster U.S. manufacturers’ market presence in China. Mr. Chen previously served as a director of Baxter International Inc. for ten years until 2023, and as a director of Cyanotech Corporation.

Victoria L. Dolan has served as a director since May 2023. Ms. Dolan served as the Chief Financial Officer of Revlon, Inc. from March 2018 through September 2022 and as Corporate Controller and Principal Accounting Officer of Colgate-Palmolive Company (‘‘Colgate’’) from 2011 through October 2017. She also served as Colgate's Chief Transformation Officer from 2016 through March 2018. She joined Colgate in 2008 as Vice President, Finance and Strategic Planning, Colgate Europe. Before joining Colgate, Ms. Dolan held multiple management positions with Marriott International, Inc. and The Coca-Cola Company. Ms. Dolan has served as a Board member of TCS Education Systems, LLC since 2018. On June 15, 2022, Revlon and certain of its subsidiaries filed voluntary petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code.

Naren K. Gursahaney has served as a director since January 2023. Mr. Gursahaney served as the Chairman of the Board of Terminix Global Holdings, Inc. (previously ServiceMaster), from May 2019 to October 2022 and as a director from December 2017 to October 2022. He served as the Interim Chief Executive Officer of ServiceMaster from January 2020 until September 2020. Mr. Gursahaney served as President and Chief Executive Officer, and as a member of the Board of Directors, of The ADT Corporation, a leading provider of security and automation solutions for homes and businesses in the United States and Canada from 2012 to 2016. Prior to ADT’s separation from Tyco International Ltd., in September 2012, Mr. Gursahaney served in various executive positions at Tyco International Ltd. from 2003 until 2012, including President of Tyco’s ADT North American Residential business segment and President of Tyco Security Solutions. Mr. Gursahaney previously worked for General Electric, Booz Allen & Hamilton and Westinghouse Electric Corp. He has been a private investor since 2016. He currently serves on the board of directors of NextEra Energy, Inc., a Fortune 200 company, where he chairs the Audit Committee, and as an Advisor and Co-chair of the Advisory Board of the Berwind Corporation.

J. Joel Hackney, Jr. has served as a director since March 2019. Mr. Hackney served as the Chief Executive Officer and a director of nThrive, Inc., a revenue cycle management company providing medical billing and coding, business analytics and advisory services, from January 2016 to February 2021. Previously, he was the Chief Executive Officer and a director of AVINTV. Mr. Hackney previously served as a director of CC Neuberger Principal Holdings III. Mr. Hackney also served on the board of directors for DJO Global, a global leader providing medical orthopedic devices and technology, from 2015 to 2019. Mr. Hackney has been a private investor and board director since 2013. 

Stephen C. Hooley has served as a director since March 2019. Mr. Hooley served as Chairman, Chief Executive Officer and President of DST Systems, Inc., a provider of advisory, technology and operations outsourcing to the financial and healthcare industries, from July 2014 to April 2018. He was Chief Executive Officer and President of DST Systems from September 2012 to July 2014 and President and Chief Operating Officer from July 2009 to September 2012. He was previously the President and Chief Executive Officer of Boston Financial Data Services. Mr. Hooley serves as a director of Brighthouse Financial, Inc. and Q2 Holdings, Inc. and served on the Board of Directors of Boston Financial Data Services and Legg Mason until it was acquired by Franklin Resources.

James L. Welch has served as a director since May 2020. Before retiring in 2018, Mr. Welch served as Chief Executive Officer of YRC Worldwide, a holding company of several brands focused on shipping and supply chain solutions in North America. In 2011, Mr. Welch re-joined YRC Worldwide from same-day transportation provider Dynamex Inc., where he had served as President and CEO since 2008. Prior to that, he served as a Consultant at Goldman Sachs Special Situations Group. Mr. Welch started his career in 1978 at Yellow Transportation, where he spent over 28 years and held multiple operations and sales positions across the organization, including President and CEO for seven years, retiring in 2007. Mr. Welch currently is the Chairman of the Board of Schneider National, Inc. where he has served as a director since 2018. He is also Lead Director at SkyWest, Inc., where he has served since 2007. He previously served on the boards of YRC Worldwide from August 2011 to July 2018, Roadrunner Transportation Systems from 2010 to 2011, Spirit Aerosystems Holdings from 2008 to 2011 and Dynamex, Inc. from 2008 to 2011.